October 12, 2026

 

Study explores potential treatment for neuropathic pain

Dr. Khalid Benamar, a professor in the Department of Neuro and Behavioral Health and the Institute of Neuroscience at the UTRGV School of Medicine, and his research team recently published a study examining the potential therapeutic effects of cannabidiol and beta-caryophyllene, a naturally occurring terpene, for peripheral neuropathy and associated neuropathic pain in HIV-1.


The study, published in Pharmaceutics, found that beta-caryophyllene demonstrated promising pain-relieving effects compared with gabapentin in a preclinical model of HIV-1-associated neuropathic pain.


Neuropathic pain can be difficult to treat, and current medications may have limited effectiveness or cause side effects. The findings point to beta-caryophyllene as a potential avenue for further research into treatments for neuropathic pain.


The study was conducted in collaboration with Dr. Manish Tripathi, associate professor at the UTRGV School of Medicine. (*Not pictured above.)


Read more here.

 
Sign for UTRGV School of Medicine with bold text in red and gray on a beige wall. Below, a red stripe displays UTRGV.edu/SOM in white.